Literature DB >> 17447434

Metal specificity of an iron-responsive element in Alzheimer's APP mRNA 5'untranslated region, tolerance of SH-SY5Y and H4 neural cells to desferrioxamine, clioquinol, VK-28, and a piperazine chelator.

S Bandyopadhyay1, X Huang, H Cho, N H Greig, M B Youdim, J T Rogers.   

Abstract

Iron closely regulates the expression of the Alzheimer's Amyloid Precursor Protein (APP) gene at the level of message translation by a pathway similar to iron control of the translation of the ferritin L- and H mRNAs by Iron-responsive Elements in their 5' untranslated regions (5'UTRs). Using transfection based assays in SH-SY5Y neuroblastoma cells we tested the relative efficiency by which iron, copper and zinc up-regulate IRE activity in the APP 5'UTR. Desferrioxamine (high affinity Fe3+ chelator), (ii) clioquinol (low affinity Fe/Cu/Zn chelator), (iii) piperazine-1 (oral Fe chelator), (iv) VK-28 (oral Fe chelator), were tested for their relative modulation of APP 5' UTR directed translation of a luciferase reporter gene. Iron chelation based therapeutic strategies for slowing the progression of Alzheimer's disease (and other neurological disorders that manifest iron imbalance) are discussed with regard to the relative neural toxic action of each chelator in SH-SY5Y cells and in H4 glioblastoma cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17447434     DOI: 10.1007/978-3-211-33328-0_25

Source DB:  PubMed          Journal:  J Neural Transm Suppl        ISSN: 0303-6995


  17 in total

1.  Site-activated chelators derived from anti-Parkinson drug rasagiline as a potential safer and more effective approach to the treatment of Alzheimer's disease.

Authors:  Hailin Zheng; Mati Fridkin; Moussa B H Youdim
Journal:  Neurochem Res       Date:  2010-10-28       Impact factor: 3.996

2.  Selective acetylcholinesterase inhibitor activated by acetylcholinesterase releases an active chelator with neurorescuing and anti-amyloid activities.

Authors:  Hailin Zheng; Moussa B H Youdim; Mati Fridkin
Journal:  ACS Chem Neurosci       Date:  2010-10-04       Impact factor: 4.418

3.  The alpha-synuclein 5'untranslated region targeted translation blockers: anti-alpha synuclein efficacy of cardiac glycosides and Posiphen.

Authors:  Jack T Rogers; Sohan Mikkilineni; Ippolita Cantuti-Castelvetri; Deborah H Smith; Xudong Huang; Sanghamitra Bandyopadhyay; Catherine M Cahill; Maria L Maccecchini; Debomoy K Lahiri; Nigel H Greig
Journal:  J Neural Transm (Vienna)       Date:  2011-01-08       Impact factor: 3.575

4.  Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

Authors:  Willam T Wang; Breeya A Tailor; David S Cohen; Xudong Huang
Journal:  EC Pharmacol Toxicol       Date:  2019-06-21

5.  Neuroprotection of brain-permeable iron chelator VK-28 against intracerebral hemorrhage in mice.

Authors:  Qian Li; Jieru Wan; Xi Lan; Xiaoning Han; Zhongyu Wang; Jian Wang
Journal:  J Cereb Blood Flow Metab       Date:  2017-05-23       Impact factor: 6.200

6.  Selective translational control of the Alzheimer amyloid precursor protein transcript by iron regulatory protein-1.

Authors:  Hyun-Hee Cho; Catherine M Cahill; Charles R Vanderburg; Clemens R Scherzer; Bin Wang; Xudong Huang; Jack T Rogers
Journal:  J Biol Chem       Date:  2010-06-17       Impact factor: 5.157

Review 7.  Alzheimer's disease therapeutics targeted to the control of amyloid precursor protein translation: maintenance of brain iron homeostasis.

Authors:  Sanghamitra Bandyopadhyay; Jack T Rogers
Journal:  Biochem Pharmacol       Date:  2014-02-07       Impact factor: 5.858

Review 8.  Iron and the translation of the amyloid precursor protein (APP) and ferritin mRNAs: riboregulation against neural oxidative damage in Alzheimer's disease.

Authors:  Jack T Rogers; Ashley I Bush; Hyan-Hee Cho; Deborah H Smith; Andrew M Thomson; Avi L Friedlich; Debomoy K Lahiri; Peter J Leedman; Xudong Huang; Catherine M Cahill
Journal:  Biochem Soc Trans       Date:  2008-12       Impact factor: 5.407

Review 9.  Amyloid precursor protein and alpha synuclein translation, implications for iron and inflammation in neurodegenerative diseases.

Authors:  Catherine M Cahill; Debomoy K Lahiri; Xudong Huang; Jack T Rogers
Journal:  Biochim Biophys Acta       Date:  2008-12-29

10.  Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases.

Authors:  Douglas B Kell
Journal:  BMC Med Genomics       Date:  2009-01-08       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.